| Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo LM Butler, DB Agus, HI Scher, B Higgins, A Rose, C Cordon-Cardo, ... Cancer research 60 (18), 5165-5170, 2000 | 848 | 2000 |
| The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin LM Butler, X Zhou, WS Xu, HI Scher, RA Rifkind, PA Marks, VM Richon Proceedings of the National Academy of Sciences 99 (18), 11700-11705, 2002 | 676 | 2002 |
| Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention LM Butler, Y Perone, J Dehairs, LE Lupien, V de Laat, A Talebi, M Loda, ... Advanced drug delivery reviews 159, 245-293, 2020 | 610 | 2020 |
| Dual roles of PARP-1 promote cancer growth and progression MJ Schiewer, JF Goodwin, S Han, JC Brenner, MA Augello, JL Dean, ... Cancer discovery 2 (12), 1134-1149, 2012 | 534 | 2012 |
| Androgen receptor inhibits estrogen receptor-α activity and is prognostic in breast cancer AA Peters, G Buchanan, C Ricciardelli, T Bianco-Miotto, MM Centenera, ... Cancer research 69 (15), 6131-6140, 2009 | 484 | 2009 |
| Tumour fatty acid metabolism in the context of therapy resistance and obesity AJ Hoy, SR Nagarajan, LM Butler Nature Reviews Cancer 21 (12), 753-766, 2021 | 352 | 2021 |
| Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer HI Scher, G Buchanan, W Gerald, LM Butler, WD Tilley Endocrine-related cancer 11 (3), 459-476, 2004 | 317 | 2004 |
| Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer G Zadra, CF Ribeiro, P Chetta, Y Ho, S Cacciatore, X Gao, S Syamala, ... Proceedings of the National Academy of Sciences 116 (2), 631-640, 2019 | 301 | 2019 |
| Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors JL Dean, AK McClendon, TE Hickey, LM Butler, WD Tilley, AK Witkiewicz, ... Cell cycle 11 (14), 2756-2761, 2012 | 269 | 2012 |
| Maximizing the therapeutic potential of HSP90 inhibitors LM Butler, R Ferraldeschi, HK Armstrong, MM Centenera, P Workman Molecular cancer research 13 (11), 1445-1451, 2015 | 259 | 2015 |
| Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease LA Selth, S Townley, JL Gillis, AM Ochnik, K Murti, RJ Macfarlane, KN Chi, ... International journal of cancer 131 (3), 652-661, 2012 | 253 | 2012 |
| Cancer-associated fibroblasts—heroes or villains? KA Gieniec, LM Butler, DL Worthley, SL Woods British journal of cancer 121 (4), 293-302, 2019 | 246 | 2019 |
| The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid DC Coffey, MC Kutko, RD Glick, LM Butler, G Heller, RA Rifkind, PA Marks, ... Cancer research 61 (9), 3591-3594, 2001 | 211 | 2001 |
| Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development T Bianco-Miotto, K Chiam, G Buchanan, S Jindal, TK Day, M Thomas, ... Cancer epidemiology, biomarkers & prévention 19 (10), 2611-2622, 2010 | 207 | 2010 |
| Minireview: the contribution of different androgen receptor domains to receptor dimerization and signaling MM Centenera, JM Harris, WD Tilley, LM Butler Molecular endocrinology 22 (11), 2373-2382, 2008 | 206 | 2008 |
| The origin and contribution of cancer-associated fibroblasts in colorectal carcinogenesis H Kobayashi, KA Gieniec, TRM Lannagan, T Wang, N Asai, Y Mizutani, ... Gastroenterology 162 (3), 890-906, 2022 | 197 | 2022 |
| The diversity and breadth of cancer cell fatty acid metabolism SR Nagarajan, LM Butler, AJ Hoy Cancer & Metabolism 9 (1), 2, 2021 | 189 | 2021 |
| Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis ZD Nassar, CY Mah, J Dehairs, IJG Burvenich, S Irani, MM Centenera, ... Elife 9, e54166, 2020 | 187 | 2020 |
| Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase LM Butler, Y Webb, DB Agus, B Higgins, TR Tolentino, MC Kutko, ... Clinical cancer research 7 (4), 962-970, 2001 | 183 | 2001 |
| Peptidomimetic targeting of critical androgen receptor–coregulator interactions in prostate cancer P Ravindranathan, TK Lee, L Yang, MM Centenera, L Butler, WD Tilley, ... Nature communications 4 (1), 1923, 2013 | 181 | 2013 |
Maggie CenteneraUniversity of AdelaideVerified email at adelaide.edu.au
